HK1053312A1 - Nuclear factor kb inducing factor - Google Patents
Nuclear factor kb inducing factorInfo
- Publication number
- HK1053312A1 HK1053312A1 HK03105529.6A HK03105529A HK1053312A1 HK 1053312 A1 HK1053312 A1 HK 1053312A1 HK 03105529 A HK03105529 A HK 03105529A HK 1053312 A1 HK1053312 A1 HK 1053312A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nfif
- polypeptides
- methods
- factor
- nfkb
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19390500P | 2000-03-31 | 2000-03-31 | |
GBGB0018307.9A GB0018307D0 (en) | 2000-07-26 | 2000-07-26 | Polypeptides |
PCT/US2001/010719 WO2001074900A2 (en) | 2000-03-31 | 2001-04-02 | Nuclear factor kb inducing factor |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1053312A1 true HK1053312A1 (en) | 2003-10-17 |
Family
ID=26244722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03105529.6A HK1053312A1 (en) | 2000-03-31 | 2003-08-01 | Nuclear factor kb inducing factor |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1290023B1 (ja) |
JP (1) | JP4750999B2 (ja) |
KR (1) | KR100811571B1 (ja) |
AT (1) | ATE486089T1 (ja) |
AU (1) | AU4793101A (ja) |
CA (1) | CA2404688C (ja) |
DE (1) | DE60143354D1 (ja) |
DK (1) | DK1290023T3 (ja) |
HK (1) | HK1053312A1 (ja) |
IL (3) | IL151987A0 (ja) |
MX (1) | MXPA02009481A (ja) |
NO (1) | NO331972B1 (ja) |
NZ (1) | NZ521786A (ja) |
PT (1) | PT1290023E (ja) |
WO (1) | WO2001074900A2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117534753B (zh) * | 2023-12-07 | 2024-05-10 | 北京博奥森生物技术有限公司 | 一种诱导高性能NF-κB多克隆抗体多肽及其应用 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0467349B1 (en) | 1983-10-20 | 2000-12-27 | The Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA |
FR2573436B1 (fr) | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
CA2108144A1 (en) | 1991-03-06 | 1992-09-07 | Jack A. Roth | Methods and compositions for the selective inhibition of gene expression |
AU3129993A (en) | 1991-11-08 | 1993-06-07 | Massachusetts Institute Of Technology | Localized oligonucleotide therapy |
EP0642589A4 (en) | 1992-05-11 | 1997-05-21 | Ribozyme Pharm Inc | METHOD AND REAGENT TO INHIBIT VIRAL REPLICATION. |
DE69334095T2 (de) | 1992-07-17 | 2007-04-12 | Dana-Farber Cancer Institute, Boston | Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen |
EP0786522A2 (en) | 1992-07-17 | 1997-07-30 | Ribozyme Pharmaceuticals, Inc. | Enzymatic RNA molecules for treatment of stenotic conditions |
EP0905253A3 (en) | 1992-12-03 | 2000-11-02 | Genzyme Corporation | Adenoviral vector deleted of all E4-ORF except ORF6 |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
FR2706486B1 (fr) | 1993-06-16 | 1995-09-01 | Rhone Poulenc Rorer Sa | Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques. |
DE69435108D1 (de) | 1993-07-13 | 2008-08-14 | Centelion | Defekte adenovirus-vektoren und deren verwendung in der gentherapie |
IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
EP0904366A1 (en) * | 1996-04-01 | 1999-03-31 | Genentech, Inc. | Apo-2li and apo-3 apoptosis polypeptides |
US6235512B1 (en) * | 1997-07-01 | 2001-05-22 | Tularik Inc. | IKK-α proteins, nucleic acids and methods |
US7122373B1 (en) * | 1998-05-14 | 2006-10-17 | Nuvelo, Inc. | Human genes and gene expression products V |
US6132964A (en) * | 1998-02-06 | 2000-10-17 | Incyte Pharmaceuticals, Inc. | Hydrolase enzymes |
GB9814036D0 (en) * | 1998-06-29 | 1998-08-26 | Univ Dundee | Materials and methods relating to the induction of apoptosis in target cells |
US6077672A (en) * | 1998-08-28 | 2000-06-20 | Isis Pharmaceuticals Inc. | Antisense modulation of TRADD expression |
CN1302897A (zh) * | 1999-10-28 | 2001-07-11 | 上海博容基因开发有限公司 | 一种新的多肽——人酸性鞘磷酯酶相似的磷酸二酯酶21和编码这种多肽的多核苷酸 |
WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
WO2001077389A2 (en) * | 2000-04-05 | 2001-10-18 | Incyte Genomics, Inc. | Genes expressed in foam cell differentiation |
WO2001094629A2 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
-
2001
- 2001-04-02 MX MXPA02009481A patent/MXPA02009481A/es active IP Right Grant
- 2001-04-02 JP JP2001572589A patent/JP4750999B2/ja not_active Expired - Fee Related
- 2001-04-02 DE DE60143354T patent/DE60143354D1/de not_active Expired - Lifetime
- 2001-04-02 DK DK01920925.3T patent/DK1290023T3/da active
- 2001-04-02 EP EP01920925A patent/EP1290023B1/en not_active Expired - Lifetime
- 2001-04-02 NZ NZ521786A patent/NZ521786A/en not_active IP Right Cessation
- 2001-04-02 IL IL15198701A patent/IL151987A0/xx unknown
- 2001-04-02 PT PT01920925T patent/PT1290023E/pt unknown
- 2001-04-02 KR KR1020027013083A patent/KR100811571B1/ko not_active IP Right Cessation
- 2001-04-02 CA CA2404688A patent/CA2404688C/en not_active Expired - Fee Related
- 2001-04-02 AT AT01920925T patent/ATE486089T1/de active
- 2001-04-02 AU AU4793101A patent/AU4793101A/xx not_active Withdrawn
- 2001-04-02 WO PCT/US2001/010719 patent/WO2001074900A2/en active Application Filing
-
2002
- 2002-09-27 NO NO20024656A patent/NO331972B1/no not_active IP Right Cessation
- 2002-09-29 IL IL151987A patent/IL151987A/en not_active IP Right Cessation
-
2003
- 2003-08-01 HK HK03105529.6A patent/HK1053312A1/xx not_active IP Right Cessation
-
2009
- 2009-04-16 IL IL198132A patent/IL198132A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60143354D1 (de) | 2010-12-09 |
IL151987A0 (en) | 2003-04-10 |
CA2404688C (en) | 2012-07-31 |
JP2003529360A (ja) | 2003-10-07 |
DK1290023T3 (da) | 2011-02-14 |
KR100811571B1 (ko) | 2008-03-10 |
AU4793101A (en) | 2001-10-15 |
MXPA02009481A (es) | 2004-05-14 |
WO2001074900A2 (en) | 2001-10-11 |
WO2001074900A9 (en) | 2003-03-06 |
NO20024656L (no) | 2002-11-28 |
JP4750999B2 (ja) | 2011-08-17 |
IL198132A0 (en) | 2011-08-01 |
EP1290023A2 (en) | 2003-03-12 |
PT1290023E (pt) | 2011-01-05 |
KR20020087459A (ko) | 2002-11-22 |
WO2001074900A3 (en) | 2002-05-02 |
ATE486089T1 (de) | 2010-11-15 |
NO331972B1 (no) | 2012-05-14 |
IL151987A (en) | 2010-12-30 |
EP1290023B1 (en) | 2010-10-27 |
NO20024656D0 (no) | 2002-09-27 |
NZ521786A (en) | 2004-07-30 |
CA2404688A1 (en) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120241T1 (el) | Χρησιμοποιηση εψιδινης για την παρασκευη ενος φαρμακου για τη θεραπεια διαταραχων της ομοιοστασης του σιδηρου | |
TR200103233T2 (tr) | Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri. | |
SE9800836D0 (sv) | New Compounds | |
ATE232396T1 (de) | Oxydiertes thymosin beta 4 | |
EP1581119A4 (en) | COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS FOR INFLAMMATORY BOWEL DISEASE | |
EP1578347A4 (en) | COMPOSITIONS AND METHODS FOR DETECTION, DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNES DISEASES | |
HUP0200493A3 (en) | Pharmaceutical compositions comprising sulphonyl-amino-carbonyl derivatives for the treatment of nuclear factor-kappa b mediated diseases | |
TR200002218T2 (tr) | 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri | |
EP1552298A4 (en) | RECOMBINANT TISSUE-PROOFING CYTOKINS AND NUCLEIC ACIDS COORDINATING THEREOF FOR THE PROTECTION, RECOVERY AND IMPROVEMENT OF CELLS, TISSUE AND ORGANS THEREOF | |
NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
SE9704644D0 (sv) | New use | |
DE60233436D1 (de) | In der mundhöhle dispergierbare feste pharmazeutische form | |
ATE266420T1 (de) | Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält | |
IL198132A0 (en) | Nuclear factor kb inducing factor | |
DK1353948T3 (da) | Oplöselige biologiske analoge til bata-amyloidpeptid | |
AP2009004857A0 (en) | Oxidized proteins, their biological activity, and therapeutic and diagnostic measures,which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof | |
DE60221501D1 (de) | Bfit (brown fat inducible thioesterase) polypeptide und polynukleotide und ihre verwendung | |
BR0109721A (pt) | Fator de indução do fator kb nuclear | |
EP0905234A3 (en) | Allelic variant of human STAT3 | |
ATE340576T1 (de) | Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit | |
ITLI20020003A1 (it) | Custodia per totanaia e simili idonea alla sicurezza antinfortunistica del pescatore e ad un uso facile di attrezzi da pesca | |
IT1294932B1 (it) | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie | |
ITBO20000360A0 (it) | Apparecchiatura di elettrostimolazione del corpo umano . | |
WO1999037774A3 (en) | Differentiation-associated sequences and methods of use therefor | |
IT1318534B1 (it) | Metodo per misurare caratteristiche meccaniche totali e regionali delsistema respiratorio umano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150402 |